Search

everythinglearnresearchcommunity

for

Search:↓

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Finasteride can cause sexual problems and depression in young men.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Finasteride worsens stress effects on sensory processes, possibly linking to anxiety/depression.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Various treatments exist for hair loss, but more research is needed for better options.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Post-finasteride syndrome's existence is uncertain; more research needed.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Using steroids can increase the risk of heart problems.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.